Cargando…

Metformin Protects Cardiovascular Health in People With Diabetes

BACKGROUND: Metformin is the most commonly used drug for patients with diabetes, but there is still some controversy about whether it has a protective effect on cardiovascular health. We therefore used the National Health and Nutritional Examination Survey (NHANES) database to analyze the impact of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Chong, Yuan, Shiqi, Zhao, Xuenuo, Qiao, Mengmeng, Li, Shuna, He, Ningxia, Huang, Liying, Lyu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314881/ https://www.ncbi.nlm.nih.gov/pubmed/35903672 http://dx.doi.org/10.3389/fcvm.2022.949113

Ejemplares similares

Competing risk analysis of cardiovascular death in patients with primary gallbladder cancer
por: Chen, Chong, et al.
Publicado: (2022)

Anti-embolism devices therapy to improve the ICU mortality rate of patients with acute myocardial infarction and type II diabetes mellitus
por: Huang, Xiaxuan, et al.
Publicado: (2022)

Corrigendum: Anti-embolism devices therapy to improve the ICU mortality rate of patients with acute myocardial infarction and type II diabetes mellitus
por: Huang, Xiaxuan, et al.
Publicado: (2023)

Protective Potential of Maresins in Cardiovascular Diseases
por: Liu, Min, et al.
Publicado: (2022)

Comorbidity of Type 2 Diabetes Mellitus and Depression: Clinical Evidence and Rationale for the Exacerbation of Cardiovascular Disease
por: Zhu, Mengmeng, et al.
Publicado: (2022)

The role of hypertension in bone mineral density among males older than 50 years and postmenopausal females: evidence from the US National Health and Nutrition Examination Survey, 2005–2010
por: Li, Shuna, et al.
Publicado: (2023)

Impact of Metabolic Syndrome and It's Components on Prognosis in Patients With Cardiovascular Diseases: A Meta-Analysis
por: Li, Xiao, et al.
Publicado: (2021)

Factors Associated With Lymph Node Yield and Effects of Lymph Node Density on Survival of Patients With Pulmonary Sarcomatoid Carcinoma
por: Huang, Liying, et al.
Publicado: (2022)

The Association Between Metformin Treatment and Outcomes in Type 2 Diabetes Mellitus Patients With Heart Failure With Preserved Ejection Fraction: A Retrospective Study
por: Wang, Jianfang, et al.
Publicado: (2021)

Metformin Suppresses the Progress of Diabetes-Accelerated Atherosclerosis by Inhibition of Vascular Smooth Muscle Cell Migration Through AMPK–Pdlim5 Pathway
por: Yan, Yi, et al.
Publicado: (2021)

The Role of Interleukin-6 Family Members in Cardiovascular Diseases
por: Feng, Yongqi, et al.
Publicado: (2022)

Knockdown of lncRNA ENST00000609755.1 Confers Protection Against Early oxLDL-Induced Coronary Heart Disease
por: Sun, Yi, et al.
Publicado: (2021)

Multi-omics insights into potential mechanism of SGLT2 inhibitors cardiovascular benefit in diabetic cardiomyopathy
por: Xi, Yangbo, et al.
Publicado: (2022)

Prediction models for cardiovascular disease risk among people living with HIV: A systematic review and meta-analysis
por: Yu, Junwen, et al.
Publicado: (2023)

Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity
por: Singh, Manrose, et al.
Publicado: (2022)

Impact of puberty, sex determinants and chronic inflammation on cardiovascular risk in young people
por: Allalou, Amal, et al.
Publicado: (2023)

Extracellular Vesicles as Protagonists of Diabetic Cardiovascular Pathology
por: Gustafson, Dakota, et al.
Publicado: (2017)

Estimated pulse wave velocity is associated with all-cause mortality and cardiovascular mortality among adults with diabetes
por: Wu, Li-Da, et al.
Publicado: (2023)

Machine learning models for predicting survival in patients with ampullary adenocarcinoma
por: Huang, Tao, et al.
Publicado: (2022)

Reduction of Vascular Inflammation, LDL-C, or Both for the Protection from Cardiovascular Events?
por: Reklou, Andromachi, et al.
Publicado: (2018)

SGLT2 Inhibitors in Diabetic Patients With Cardiovascular Disease or at High Cardiovascular Risk: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Zhao, Zinan, et al.
Publicado: (2022)

Association between statin use and the prognosis of patients with acute myocardial infarction complicated with diabetes
por: Lu, Xuehao, et al.
Publicado: (2022)

Association Between Metformin and Abdominal Aortic Aneurysm: A Meta-Analysis
por: Niu, Wenqiang, et al.
Publicado: (2022)

The Association Between Exposure to Acrylamide and Mortalities of Cardiovascular Disease and All-Cause Among People With Hyperglycemia
por: Wu, Huanyu, et al.
Publicado: (2022)

The Intersection of Diabetes and Cardiovascular Disease—A Focus on New Therapies
por: Dhindsa, Devinder S., et al.
Publicado: (2018)

Postprandial Glucose Spikes, an Important Contributor to Cardiovascular Disease in Diabetes?
por: Hanssen, Nordin M. J., et al.
Publicado: (2020)

Diabetes and Its Cardiovascular Complications: Comprehensive Network and Systematic Analyses
por: Wu, Hao, et al.
Publicado: (2022)

Editorial: New mechanisms and drugs for the treatment of cardiovascular disease with diabetes
por: Zhang, Shanshan, et al.
Publicado: (2023)

Intakes of folate, vitamin B6, and vitamin B12 and cardiovascular disease risk: a national population-based cross-sectional study
por: Huang, Jiamin, et al.
Publicado: (2023)

Patient-centred care, health behaviours and cardiovascular risk factor levels in people with recently diagnosed type 2 diabetes: 5-year follow-up of the ADDITION-Plus trial cohort
por: Dambha-Miller, Hajira, et al.
Publicado: (2016)

Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial)
por: Zoungas, Sophia, et al.
Publicado: (2023)

Prediction and Risk Stratification of Cardiovascular Disease in Diabetic Kidney Disease Patients
por: Ren, Jingjing, et al.
Publicado: (2022)

Protection of diabetes in aortic abdominal aneurysm: Are antidiabetics the real effectors?
por: Picatoste, Belén, et al.
Publicado: (2023)

Editorial: Insights in cardiovascular therapeutics: 2021 – cell death, cardiovascular injuries, and novel targets of cardiovascular therapeutics
por: Xu, Keman, et al.
Publicado: (2022)

Deep transfer learning to quantify pleural effusion severity in chest X-rays
por: Huang, Tao, et al.
Publicado: (2022)

How dysregulation of the immune system promotes diabetes mellitus and cardiovascular risk complications
por: Girard, Diane, et al.
Publicado: (2022)

Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study
por: Yang, Sheng-Hua, et al.
Publicado: (2017)

Understanding the barriers and facilitators that influence access to quality cardiovascular care for rural Indigenous peoples: protocol for a scoping review
por: Tane, Taria, et al.
Publicado: (2022)

Association between visceral obesity and 10-year risk of first atherosclerotic cardiovascular diseases events among American adults: National Health and Nutrition Examination Survey
por: Zheng, Liying, et al.
Publicado: (2023)

A Nomogram for Predicting Survival in Patients With Colorectal Cancer Incorporating Cardiovascular Comorbidities
por: Wang, Hao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j0p184qfliugf9mqpj8rsg8i2g